Table 1 Characterization of Patient and Prior Treatments
Patient | Age (Years) | Sex | HPV type | Age at diagnosis (Years) | Number of RRP surgeries lifetime | Prior local treatments | Prior systemic treatments | Pulmonary RRP lesions |
|---|---|---|---|---|---|---|---|---|
1 | 32 | F | 11 | 19 | > 40 | Cidofovir | I-3-C | No |
2 | 36 | M | 6 | 28 | 35 | Cidovofir, bevacizumab | I-3-C | No |
3 | 50 | F | 11 | 5 | > 250 | Mitomycin | Diindolylmethane | Yes |
4 | 63 | M | 11 | 19 | > 50 | Cidofovir, Cryotherapy | None | No |
5 | 27 | F | 6 | 6 | > 50 | None | None | No |
6 | 53 | F | 11 | 38 | > 20 | Cidofovir | None | Yes |
7 | 55 | M | 6 | 53 | 11 | Cidovofir, bevacizumab | None | No |
8 | 55 | F | 6 | 51 | 16 | None | None | No |
9 | 56 | M | 11 | 54 | > 20 | Cidofovir | None | No |
10 | 21 | M | 6 | 1 | > 100 | Cidovofir, bevacizumab | Interferon, Methotrexate | Yes |
11 | 67 | M | 6 | 28 | > 40 | bevacizumab, PDT | I-3-C | Yes |
12 | 26 | M | 11 | 2 | > 100 | Cidofovir, bevacizumab | Interferon, I-3-C | No |